Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
|
IT |
|
N
|
Nsys Co Ltd
KOSDAQ:333620
|
KR |
|
Churchill Capital Corp VII
NASDAQ:CVII
|
US |
|
CJ Corp
KRX:001040
|
KR |
|
Despegar.com Corp
NYSE:DESP
|
AR |
Wall Street
Price Targets
REC Price Targets Summary
Recordati Industria Chimica e Farmaceutica SpA
According to Wall Street analysts, the average 1-year price target for
REC
is 59.3 EUR
with a low forecast of 48.48 EUR and a high forecast of 74.55 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is REC's stock price target?
Price Target
59.3
EUR
According to Wall Street analysts, the average 1-year price target for
REC
is 59.3 EUR
with a low forecast of 48.48 EUR and a high forecast of 74.55 EUR.
What is Recordati Industria Chimica e Farmaceutica SpA's Operating Income forecast?
Projected CAGR
12%
For the last 13 years the
compound annual growth rate for
Recordati Industria Chimica e Farmaceutica SpA's operating income is
11%.
The projected
CAGR
for the next 4 years is
12%.
What is Recordati Industria Chimica e Farmaceutica SpA's Net Income forecast?
Projected CAGR
17%
For the last 13 years the
compound annual growth rate for
Recordati Industria Chimica e Farmaceutica SpA's net income is
10%.
The projected
CAGR
for the next 4 years is
17%.
